AVITA Medical (AVHHL) Common Equity (2019 - 2025)

AVITA Medical has reported Common Equity for 7 years, with the latest figure at -$16.6 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity fell 470.08% year-over-year to -$16.6 million; the trailing twelve-month figure through Dec 2025 stood at -$16.6 million (down 470.08% YoY), and the FY2025 full-year result was -$16.6 million, down 470.08% from the prior year.
• Common Equity for Q4 2025 stood at -$16.6 million, down from -$6.7 million in the prior quarter.
• The five-year high for Common Equity was $118.9 million in Q1 2021, with the low at -$16.6 million in Q4 2025.
• Historically, Common Equity has averaged $55.2 million across 5 years, with a median of $65.8 million in 2023.
• Annual changes were most pronounced in 2021 — Common Equity soared 75.55% — and 2025, when it sank 470.08%.
• AVITA Medical's Common Equity stood at $104.6 million in 2021, then slipped by 19.01% to $84.7 million in 2022, then tumbled by 42.11% to $49.1 million in 2023, then slumped by 90.83% to $4.5 million in 2024, then slumped by 470.08% to -$16.6 million in 2025.
• The last three Common Equity figures came in at -$16.6 million (Q4 2025), -$6.7 million (Q3 2025), and -$12.9 million (Q2 2025), per Business Quant data.